March 6 – Update on NIH indirect cost rates

A federal judge on March 5 issued a nationwide preliminary injunction that halts the implementation of a 15% indirect cost rate on NIH grants and contracts. The injunction, which replaces the temporary restraining order on the cuts placed last month, will likely remain in place until the judge hears full arguments in three lawsuits brought forward by 22 state attorneys general, associations, and organizations representing institutions of higher education.

NASDA action supporting continued funding for Dairy Business Innovation Centers

On Feb. 26, the National Association of State Departments of Agriculture (NASDA) passed an action item supporting continued funding for the four national Dairy Business Innovation Centers, including the Dairy Business Innovation Alliance (DBIA), which is a partnership between the Center for Dairy Research and the Wisconsin Cheese Makers Association that is housed at UW–Madison.

Feb. 14 update

Several media outlets are reporting that federal employees, including some agencies that the university works with closely, have been receiving notice of layoffs. The Office of Federal Relations is continuing to monitor these and other developments and the potential impact on UW-Madison operations.

A threat to research for the public good

A message from university leaders on National Institutes of Health (NIH)’s announced reduction in how it would provide funding to schools like UW–Madison for the expenses associated with doing grant-funded scientific and medical research. Update: A temporary restraining order was granted in the case of 22 states, including Wisconsin, filing suit against the NIH and its 15% funding cap on indirect costs. The court action blocks the changes. A hearing has been scheduled for Feb. 21.

Important NIH Update: Indirect Cost Rate Cap

We want to make you aware of an important change announced by National Institutes of Health on Friday, Feb. 7. The NIH has implemented a standardized indirect cost (IDC) rate of 15% across all NIH grants, replacing individually negotiated rates. This applies to both new grants and existing grants retroactively to the date of issuance of this guidance.